Meta-Analysis: Efficacy and Safety of Inhaled Insulin Therapy in Adults with Diabetes Mellitus
作者： Lisa Ceglia , Joseph Lau , Anastassios G. Pittas
DOI: 10.7326/0003-4819-145-9-200611070-00009
关键词:
摘要: This systematic review of 16 randomized trials in adult patients with type 1 or 2 diabetes found that inhaled insulin reduced hemoglobin A1c levels slightly less than subcutaneous and ...
sci-hub.st 参考文章(37)
R. A. DeFronzo, R. M. Bergenstal, W. T. Cefalu, J. Pullman, S. Lerman, B. W. Bode, L. S. Phillips, , Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial Diabetes Care. ,vol. 28, pp. 1922- 1928 ,(2005) , 10.2337/DIACARE.28.8.1922
K. Hermansen, T. Ronnemaa, A. H. Petersen, S. Bellaire, U. Adamson, Intensive Therapy With Inhaled Insulin via the AERx Insulin Diabetes Management System: A 12-week proof-of-concept trial in patients with type 2 diabetes Diabetes Care. ,vol. 27, pp. 162- 167 ,(2004) , 10.2337/DIACARE.27.1.162
Mustafa Toma, Finlay A. McAlister, Liza Bialy, Denise Adams, Ben Vandermeer, Paul W. Armstrong, Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA. ,vol. 295, pp. 1281- 1287 ,(2006) , 10.1001/JAMA.295.11.1281
Robert C Turner, Carole A Cull, Valeria Frighi, Rury R Holman, UK Prospective Diabetes Study (UKPDS) Group, UK Prospective Diabetes Study (UKPDS) Group, None, Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49) JAMA. ,vol. 281, pp. 2005- 2012 ,(1999) , 10.1001/JAMA.281.21.2005
Julio Rosenstock, Bernard Zinman, Liam J Murphy, Stephen C Clement, Paul Moore, C Keith Bowering, Rosa Hendler, Shu-Ping Lan, William T Cefalu, Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes: A Randomized, Controlled Trial Annals of Internal Medicine. ,vol. 143, pp. 549- 558 ,(2005) , 10.7326/0003-4819-143-8-200510180-00005
F. Innocenti, A. Fabbri, R. Anichini, S. Tuci, G. Pettinà, F. Vannucci, L.A. De Giorgio, G. Seghieri, Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus☆ Diabetes Research and Clinical Practice. ,vol. 25, pp. 161- 168 ,(1994) , 10.1016/0168-8227(94)90004-3
T. Quattrin, A. Belanger, N. J.V. Bohannon, S. L. Schwartz, , Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes Results of a 6-month, randomized, comparative trial Diabetes Care. ,vol. 27, pp. 2622- 2627 ,(2004) , 10.2337/DIACARE.27.11.2622
John M. Eisenberg, Ten lessons for evidence-based technology assessment. JAMA. ,vol. 282, pp. 1865- 1869 ,(1999) , 10.1001/JAMA.282.19.1865
Priscilla A Hollander, Lawrence Blonde, Richard Rowe, Adi E Mehta, Joseph L Milburn, Kenneth S Hershon, Jean-Louis Chiasson, Seymour R Levin, Exubera Phase III Study Group, Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes: Results of a 6-month, randomized, comparative trial Diabetes Care. ,vol. 27, pp. 2356- 2362 ,(2004) , 10.2337/DIACARE.27.10.2356
Joseph C. Cappelleri, William T. Cefalu, Julio Rosenstock, Ione A. Kourides, Robert A. Gerber, Treatment satisfaction in type 2 diabetes: A comparison between an inhaled insulin regimen and a subcutaneous insulin regimen Clinical Therapeutics. ,vol. 24, pp. 552- 564 ,(2002) , 10.1016/S0149-2918(02)85131-1